vimarsana.com

இந்தியா அடிப்படையிலானது இன்டாஸ் மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI® for the Treatment of Advanced Prostate Cancer; Accord BioPharma to Head the U S Commercialization

/PRNewswire/ Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug.

T ai peiBen chienChrys kokinoPharmaceuticals co ltdPrnewswire foresee pharmaceuticalsIntas pharmaceuticals ltdDrug administrationTaipei exchangePharmaceuticals coNew drug applicationStabilized injectable formulationProstate carcinomaAccord biopharmaSafety informationFanconi anemiaIndia based intas pharmaceuticals

Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI for the Treatment of Advanced Prostate Cancer; Accord BioPharma to Head the U S Commercialization

TAIPEI, May 27, 2021 /PRNewswire/ Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA)

T ai peiBen chienKostenloser wertpapierhandelChrys kokinoPrnewswire foresee pharmaceuticalsIntas pharmaceuticals ltdDrug administrationTaipei exchangePharmaceuticals coNew drug applicationStabilized injectable formulationProstate carcinomaAccord biopharmaSafety informationFanconi anemiaIndia based intas pharmaceuticals

vimarsana © 2020. All Rights Reserved.